<--- Back to Details
First PageDocument Content
Health / Pharmaceutical sciences / Pharmaceutical industry / Food and Drug Administration / Advertising / Direct-to-consumer advertising / Unnecessary health care / Prescription Drug User Fee Act / Criticism of the Food and Drug Administration
Date: 2008-05-08 13:43:30
Health
Pharmaceutical sciences
Pharmaceutical industry
Food and Drug Administration
Advertising
Direct-to-consumer advertising
Unnecessary health care
Prescription Drug User Fee Act
Criticism of the Food and Drug Administration

United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight

Add to Reading List

Source URL: www.gao.gov

Download Document from Source Website

File Size: 265,24 KB

Share Document on Facebook

Similar Documents

Cutting Edge: Our weekly analysis of marketing news 15 June 2016 Welcome to our weekly analysis of the most useful marketing news for CIM and CAM members. Quick links to sections

Cutting Edge: Our weekly analysis of marketing news 15 June 2016 Welcome to our weekly analysis of the most useful marketing news for CIM and CAM members. Quick links to sections

DocID: 1rtni - View Document

United States Government Accountability Office  GAO Testimony Before the Subcommittee on Oversight

United States Government Accountability Office GAO Testimony Before the Subcommittee on Oversight

DocID: 1rfHg - View Document

March 2016 Vol. 15, No. 2 • Pharma Marketing Network® www.pharmamarketingnews.com

March 2016 Vol. 15, No. 2 • Pharma Marketing Network® www.pharmamarketingnews.com

DocID: 1pXw4 - View Document

Letter to FTC re Jeunesse

Letter to FTC re Jeunesse

DocID: 1pQzu - View Document

Microsoft Word - maporreport_final2.doc

Microsoft Word - maporreport_final2.doc

DocID: 1pcgT - View Document